Market Overview

Novavax Shares Up 0.5%; Wedbush Issues Mid-Day Note Reiterating Outperform Rating, $14 Target, Says 'Thinking about Pivotal RSV Data Coming This Quarter'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for NVAX

DateFirmActionFromTo
Sep 2016Chardan CapitalMaintainsNeutral
Sep 2016CitigroupMaintainsNeutral
Sep 2016JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for NVAX
View the Latest Analyst Ratings

Posted-In: Analyst Color Price Target Reiteration Analyst Ratings

 

Related Articles (NVAX)